Metabolic Comparison

5-Amino-1MQ vs Retatrutide

Comparison of 5-Amino-1MQ (Low evidence) and Retatrutide (High evidence).

Last updated: February 12, 2026

5-Amino-1MQ

Low Evidence
View full dossier

Retatrutide

High Evidence
View full dossier

Overview

5-Amino-1MQ and Retatrutide are both studied in the peptide research space.

5-Amino-1MQ: A small molecule NNMT inhibitor studied for metabolic effects in animal models.

Retatrutide: A triple GIP/GLP-1/glucagon receptor agonist in Phase 3 development.

Evidence Comparison

Aspect5-Amino-1MQRetatrutide
Evidence LevelLowHigh
Human Studies115
Preclinical Studies116
Total Sources12124

Key Differences

Aspect5-Amino-1MQRetatrutide
CategoryMetabolicMetabolic
Evidence StrengthLowHigh
Total Sources12124
Human Studies115

Summary

  • 5-Amino-1MQ: Low evidence with 12 total sources (1 human)
  • Retatrutide: High evidence with 124 total sources (15 human)

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.

Stay Updated on Peptide Comparisons

Get notified when we publish new comparison dossiers and evidence reviews.

No spam. Unsubscribe anytime.

Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.